Keytruda is a medicine that's used to treat certain cancers by working with your body's immune system to detect and destroy cancer cells (called immunotherapy). Keytruda belongs to a group of medicines called immune checkpoint inhibitors.
Read more about immune checkpoint inhibitors and how they work.
In Aotearoa New Zealand, Keytruda is funded for people who meet the eligibility criteria and have:
- metastatic melanoma
- advanced or metastatic non-small cell lung cancer (NSCLC).
From 1 October 2024, Keytruda will be funded for people who meet the eligibility criteria and have:
- advanced triple-negative breast cancer(external link)
- recurrent or metastatic head and neck cancer(external link)
- unresectable or metastatic colorectal (bowel) cancer(external link)
- advanced urothelial carcinoma (bladder)(external link)
- relapsed or refractory Hodgkin lymphoma (a type of blood cancer).(external link)